Supplementary Scheme Booklet
Filed with ASX · · 13 pages · English
Summary by 6ix AI
Little Green Pharma Ltd. has released a Supplementary Scheme Booklet regarding its proposed acquisition of Cannatrek Ltd. through a scheme of arrangement. The booklet includes updated information about the scheme's timetable and an update on the sale and leaseback of a production facility in Western Australia. The Independent Expert has concluded that the scheme remains in the best interests of Cannatrek shareholders, and both boards recommend voting in favor of the scheme. The document is intended to assist Cannatrek shareholders in making informed decisions ahead of the upcoming scheme meeting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Little Green Pharma Ltd. on 6ix
Story so far
Earlier from Little Green Pharma
- Termination of proposed sale and leaseback transaction
- Scheme Booklet Registered by ASIC
- Proposed sale of WA production facility
- Quarterly Activities Report and Appendix 4C
- Transformational Merger of LGP and Cannatrek
Later from Little Green Pharma
- Scheme Approved by Cannatrek Shareholders
- Scheme Update
- Updated second court date and indicative timetable
- Transaction Update and General Meeting Update
- Appendix 4E and 2026 Annual Report
Follow Little Green Pharma into a list and get an email when it puts out news.
Follow Little Green Pharma